Discover 1,727 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,727
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Bloomfield Hills MI, Avon Lake OH, Westlake OH,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase 3, Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for
Obstructive Hypertrophic Cardiomyopathy
Location: West Bloomfield MI, Cleveland OH, Grand Rapids MI,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05489705
Recruiting
Sleep to Reduce Incident Depression Effectively in Peripartum
for
Insomnia, Depression
Location: Novi MI
Sponsor: Henry Ford Health System
Sex: Female
Age: 18+
Code: NCT06430333
Phase 2, Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
for
Adjustment Disorder
Location: Novi MI, Ann Arbor MI, Cleveland OH, Columbus OH,
Sponsor: Reunion Neuroscience Inc
Sex: All
Age: 18 - 70+
Code: NCT07002034
Phase 2, Recruiting
Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms
for
Menopausal Women, Insomnia
Location: Novi MI, Pittsburgh PA, Boston MA, Salt Lake City UT
Sponsor: Brigham and Women's Hospital
Sex: Female
Age: 40 - 62
Code: NCT07136415
Recruiting
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
for
Narcolepsy Type 1
Location: Novi MI, Cleveland OH, Dublin OH, Cincinnati OH,
Sponsor: Takeda
Sex: All
Age: 16 - 70
Code: NCT05816382
Phase 2, Phase 3, Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)